Medical Equipment | Hospital Management | Senior Care | Pharmaceuticals
JFP Holdings has worked with medical device, hospital management and developmental drug companies to bring their products, services and technologies to China.
Health care spending in China is projected to more than double to $1 trillion by 2020. Even at that level, China’s health care industry will only be one-third the size of the United States, and spending will be less than $1,000 per person, compared to approximately $9,000 in America. China’s large, aging and increasingly affluent population ensures high growth in health care spending for many years to come.
Health care is one of the last big industries in China to open up to foreign investment and technology. In addition to rising demand for the best available treatment, China is facing new challenges as cancer, heart disease, diabetes and other chronic diseases afflict more of its population. According to the World Health Organization, three million new cases of cancer are diagnosed every year in China, almost 22 percent of the total globally; approximately 230 million Chinese suffer from cardiovascular disease; and approximately 114 million adults are afflicted by diabetes.
Read more on Healthcare: